Abstract | BACKGROUND:
Tumor metastasis is a main cause of death in patients with breast cancer. The cross-talk between cancer-associated fibroblasts (CAFs) and tumor cells plays an important role in promoting tumor invasion and metastasis. It is important to develop a novel delivery system to inhibit tumor development by simultaneously targeting both CAFs and tumor cells. OBJECTIVES: The main objective of this research was to prepare nanoparticles to inhibit tumor proliferation and migration by blocking the cross-talk of tumor-CAFs. Additionally, a novel "MCF- 7+NIH/3T3" mixed cell model was established to mimic the tumor microenvironment (TME). METHODS: In this study, the pH-responsive nanoparticles (MIF/DOX-sul-HA NPs) based on sulfated hyaluronic acid (sul-HA) polymers were prepared for co-delivery of doxorubicin (DOX) and mifepristone (MIF). The effects of anti-proliferation and anti- metastasis of MIF/DOX-sul-HA NPs were investigated both in vitro and in vivo. RESULTS: The results showed that MIF/DOX-sul-HA NPs were nearly spherical in shape with narrow particle size distribution and pH-responsive drug release, and could be taken up by both MCF-7 and NIH/3T3 cells. Compared with MCF-7 cells alone, the anti- tumor effect of single DOX was weak in the "MCF-7+NIH/3T3" mixed cell model. MIF/DOX-sul-HA NPs exhibited strong effects of anti-proliferation and anti- metastasis than the free single drug. CONCLUSION: The sul-HA nanoparticles for co-delivery of DOX and MIF could be a promising combined therapy strategy for the treatment of breast cancer.
|
Authors | Di Wang, Jingliang Wu, Cuiping Qi, Jinping Dong, Xueying Ding, Guohua Yu, Shuzhen Liu, Bo Zhang, Zhiqin Gao, Xiuhong Wei, Hongying Liu |
Journal | Recent patents on anti-cancer drug discovery
(Recent Pat Anticancer Drug Discov)
Vol. 18
Issue 2
Pg. 200-210
( 2022)
ISSN: 2212-3970 [Electronic] United Arab Emirates |
PMID | 35538821
(Publication Type: Journal Article)
|
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at [email protected]. |
Chemical References |
- Hyaluronic Acid
- Sulfates
- Doxorubicin
|
Topics |
- Mice
- Animals
- Humans
- Female
- Breast Neoplasms
(drug therapy)
- Hyaluronic Acid
(pharmacology, therapeutic use)
- Sulfates
(therapeutic use)
- Cancer-Associated Fibroblasts
- Doxorubicin
(pharmacology, therapeutic use)
- Nanoparticles
- MCF-7 Cells
- Hydrogen-Ion Concentration
- Drug Delivery Systems
(methods)
- Tumor Microenvironment
|